Clinical Research Directory
Browse clinical research sites, groups, and studies.
Magnesium and Riboflavin Treatment for Post-Concussion Headache
Sponsor: University of Virginia
Summary
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
108
Start Date
2020-02-10
Completion Date
2025-12-31
Last Updated
2025-03-27
Healthy Volunteers
No
Conditions
Interventions
magnesium and riboflavin supplement
Five capsules considered one dose of the intervention (one 400 mg magnesium capsule and four 100 mg riboflavin capsules)
Locations (1)
University of Virginia Student Health and Wellness Center
Charlottesville, Virginia, United States